203 related articles for article (PubMed ID: 23782334)
1. Gastric adenocarcinoma of the fundic gland type shares common genetic and phenotypic features with pyloric gland adenoma.
Kushima R; Sekine S; Matsubara A; Taniguchi H; Ikegami M; Tsuda H
Pathol Int; 2013 Jun; 63(6):318-25. PubMed ID: 23782334
[TBL] [Abstract][Full Text] [Related]
2. Morphology and genetics of pyloric gland adenomas in familial adenomatous polyposis.
Hackeng WM; Montgomery EA; Giardiello FM; Singhi AD; Debeljak M; Eshleman JR; Vieth M; Offerhaus GJ; Wood LD; Brosens LA
Histopathology; 2017 Mar; 70(4):549-557. PubMed ID: 27767239
[TBL] [Abstract][Full Text] [Related]
3. Pyloric gland adenoma: an entity distinct from gastric foveolar type adenoma.
Chen ZM; Scudiere JR; Abraham SC; Montgomery E
Am J Surg Pathol; 2009 Feb; 33(2):186-93. PubMed ID: 18830123
[TBL] [Abstract][Full Text] [Related]
4. Frequent GNAS and KRAS mutations in pyloric gland adenoma of the stomach and duodenum.
Matsubara A; Sekine S; Kushima R; Ogawa R; Taniguchi H; Tsuda H; Kanai Y
J Pathol; 2013 Mar; 229(4):579-87. PubMed ID: 23208952
[TBL] [Abstract][Full Text] [Related]
5. Next-generation sequencing identifies 2 genomically distinct groups among pyloric gland adenomas.
Setia N; Wanjari P; Yassan L; Niu N; Kadri S; Ritterhouse L; Misdraji J; Brown I; Segal J; Hart J
Hum Pathol; 2020 Mar; 97():103-111. PubMed ID: 31783043
[TBL] [Abstract][Full Text] [Related]
6. GNAS mutation as an alternative mechanism of activation of the Wnt/β-catenin signaling pathway in gastric adenocarcinoma of the fundic gland type.
Nomura R; Saito T; Mitomi H; Hidaka Y; Lee SY; Watanabe S; Yao T
Hum Pathol; 2014 Dec; 45(12):2488-96. PubMed ID: 25288233
[TBL] [Abstract][Full Text] [Related]
7. Pyloric gland adenoma: a histologic, immunohistochemical and molecular genetic study of 23 cases.
Chlumská A; Waloschek T; Mukenšnabl P; Martínek P; Kašpírková J; Zámečník M
Cesk Patol; 2015; 51(3):137-43. PubMed ID: 26421956
[TBL] [Abstract][Full Text] [Related]
8. Pyloric Gland Adenoma (PGA) of the Gallbladder: A Unique and Distinct Tumor from PGAs of the Stomach, Duodenum, and Pancreas.
He C; Fukumura Y; Toriyama A; Ogura K; Sasahara N; Mitani K; Yao T
Am J Surg Pathol; 2018 Sep; 42(9):1237-1245. PubMed ID: 29975247
[TBL] [Abstract][Full Text] [Related]
9. Familial adenomatous polyposis-associated and sporadic pyloric gland adenomas of the upper gastrointestinal tract share common genetic features.
Hashimoto T; Ogawa R; Matsubara A; Taniguchi H; Sugano K; Ushiama M; Yoshida T; Kanai Y; Sekine S
Histopathology; 2015 Nov; 67(5):689-98. PubMed ID: 25832318
[TBL] [Abstract][Full Text] [Related]
10. Gastric adenocarcinoma of fundic gland type (chief cell predominant type): proposal for a new entity of gastric adenocarcinoma.
Ueyama H; Yao T; Nakashima Y; Hirakawa K; Oshiro Y; Hirahashi M; Iwashita A; Watanabe S
Am J Surg Pathol; 2010 May; 34(5):609-19. PubMed ID: 20410811
[TBL] [Abstract][Full Text] [Related]
11. Diffuse MIST1 expression and decreased α1,4-linked N-acetylglucosamine (αGlcNAc) glycosylation on MUC6 are distinct hallmarks for gastric neoplasms showing oxyntic gland differentiation.
Yamada S; Yamanoi K; Sato Y; Nakayama J
Histopathology; 2020 Sep; 77(3):413-422. PubMed ID: 32502322
[TBL] [Abstract][Full Text] [Related]
12. Decreased expression of gastric gland mucin-specific glycan α1,4-linked N-acetylglucosamine on its scaffold mucin 6 is associated with malignant potential of pyloric gland adenoma of the stomach.
Yamanoi K; Sekine S; Higuchi K; Kushima R; Nakayama J
Histopathology; 2015 Dec; 67(6):898-904. PubMed ID: 25929994
[TBL] [Abstract][Full Text] [Related]
13. Gastric adenocarcinoma with chief cell differentiation: a proposal for reclassification as oxyntic gland polyp/adenoma.
Singhi AD; Lazenby AJ; Montgomery EA
Am J Surg Pathol; 2012 Jul; 36(7):1030-5. PubMed ID: 22472957
[TBL] [Abstract][Full Text] [Related]
14. Alteration in the Wnt/β-catenin signaling pathway in gastric neoplasias of fundic gland (chief cell predominant) type.
Hidaka Y; Mitomi H; Saito T; Takahashi M; Lee SY; Matsumoto K; Yao T; Watanabe S
Hum Pathol; 2013 Nov; 44(11):2438-48. PubMed ID: 24011952
[TBL] [Abstract][Full Text] [Related]
15. Distinct Involvement of the Sonic Hedgehog Signaling Pathway in Gastric Adenocarcinoma of Fundic Gland Type and Conventional Gastric Adenocarcinoma.
Tajima Y; Murakami T; Saito T; Hiromoto T; Akazawa Y; Sasahara N; Mitomi H; Yao T; Watanabe S
Digestion; 2017; 96(2):81-91. PubMed ID: 28738329
[TBL] [Abstract][Full Text] [Related]
16. Gastric pyloric gland adenoma: a multicentre clinicopathological study of 67 cases.
Choi WT; Brown I; Ushiku T; Yozu M; Setia N; Srivastava A; Johncilla M; Pai RK; Gill RM; Fukayama M; Misdraji J; Lauwers GY
Histopathology; 2018 May; 72(6):1007-1014. PubMed ID: 29278427
[TBL] [Abstract][Full Text] [Related]
17. Duodenal Neoplasms of Gastric Phenotype: An Immunohistochemical and Genetic Study With a Practical Approach to the Classification.
Hida R; Yamamoto H; Hirahashi M; Kumagai R; Nishiyama K; Gi T; Esaki M; Kitazono T; Oda Y
Am J Surg Pathol; 2017 Mar; 41(3):343-353. PubMed ID: 27984236
[TBL] [Abstract][Full Text] [Related]
18. Sporadic pyloric gland adenoma associated with a large fundic gland polyp: genetic evidence for stepwise progression.
Nonaka S; Hashimoto T; Oda I; Sekine S
Gastric Cancer; 2020 Nov; 23(6):1102-1106. PubMed ID: 32415517
[TBL] [Abstract][Full Text] [Related]
19. Co-expression of gastric and biliary phenotype in pyloric-gland type adenoma of the gallbladder: immunohistochemical analysis of mucin profile and CD10.
Nagata S; Ajioka Y; Nishikura K; Watanabe G; Inoue T; Yamaguchi K; Watanabe H; Tanaka M; Tsuneyoshi M
Oncol Rep; 2007 Apr; 17(4):721-9. PubMed ID: 17342306
[TBL] [Abstract][Full Text] [Related]
20. An immunohistochemical profile of the so-called bile duct adenoma: clues to pathogenesis.
Hughes NR; Goodman ZD; Bhathal PS
Am J Surg Pathol; 2010 Sep; 34(9):1312-8. PubMed ID: 20679879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
